CassandraBio
Pipeline dossier

NIH & clinical-trial pipeline signals for INNO HOLDINGS INC. (INHD)

Leading indicators across the NIH grant → clinical trial → SEC filing chain for INHD, mapped to public ticker INHD (CIK 0001961847). Sourced live from public data.

⚠ Research/informational signals from public data (NIH · ClinicalTrials.gov · SEC EDGAR). Not investment advice. Full scope →
Trial → FilingINHD55% conf

INNO HOLDINGS INC. (INHD) — trial primary completion in ~28 days

Upstream (observed)
Clinical trial status (n/a) — Long-term Observational Study to Evaluate the DFS and OS of Adjuvant FOLFIRINOX Regimen in Pancreatic Cancer Patients
↓ days–weeks to disclosure
Predicted downstream
SEC 8-K / press release (material trial update) (days–weeks)
trial ↗filings ↗

Recent SEC 8-K filings

JSON API for this entity →